Low dose of vitamin D not associated with depression benefits

- Last updated on GMT

Related tags: Vitamin d3, Vitamin d

Low dose of vitamin D not associated with depression benefits
A daily dose of 400 IU of vitamin D3 plus 1,000 mg of calcium was not associated with symptoms of depression, says a new study.

Data from 36,282 postmenopausal women participating in the Women’s Health Initiative indicated that two years of supplementation did not reduce antidepressant use or continuous depressive symptoms.

The study’s findings, published in the American Journal of Epidemiology​, are at odds with other studies that have reported an association between vitamin D levels and lower incidence of symptoms of depression.

“The findings do not support a relation between supplementation with 400 IU/day of vitamin D3 along with calcium and depression in older women,”​ wrote researchers led by Elizabeth Bertone-Johnson from the University of Massachusetts.

“Additional trials testing higher doses of vitamin D are needed to determine whether this nutrient may help prevent or treat depression.”

Data from 81,189 participants of the Women's Health Initiative (WHI) Observational Study published in the American Journal of Clinical Nutrition​ indicated that the prevalence of depressive symptoms was 21% lower for women with daily vitamin D intakes exceeding 800 International Units (IU) per day, compared with intakes of less than 100 IU per day.

Source: American Journal of Epidemiology
Published online ahead of print, doi:10.1093/aje/kwr482
“Vitamin D Supplementation and Depression in the Women’s Health Initiative Calcium and Vitamin D Trial”
Authors: E.R. Bertone-Johnson, S.I. Powers, L. Spangler, J. Larson, et al.

Related news

Show more

Related products

show more

Breakthrough in Women's Health

Breakthrough in Women's Health

Biosearch Life | 08-Apr-2019 | Clinical Study

A new study performed on women with polycystic ovary syndrome (PCOS) and fertility problems has been published in Gynecological Endocrinology. Results...

MenaQ7® K2: Patent Protection, Confirmed Benefits

MenaQ7® K2: Patent Protection, Confirmed Benefits

NattoPharma USA, Inc. | 25-Mar-2019 | Data Sheet

Vitamin K2 is the new cardio-support nutrient because clinical studies have confirmed it delivers what no other compound can: reduction in arterial stiffening.

Resveratrol & Cognition: a Winning Combination

Resveratrol & Cognition: a Winning Combination

Evolva | 25-Mar-2019 | Infographic

Brain health is top of mind for consumers, and research indicates that resveratrol can be effective in maintaining memory, processing, and reasoning that...

Pycnogenol® for Enhanced Cognitive Performance

Pycnogenol® for Enhanced Cognitive Performance

Horphag Research | 20-Mar-2019 | Infographic

Pycnogenol®, French maritime pine bark extract has been found safe and effective to support brain function in a variety of age groups from college students...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars